Monday, May 07, 2012 11:26:31 AM
Today : Monday 7 May 2012
Herborium Group, Inc., (PINKS. HBRM) www.herborium.com, a Botanical Therapeutics® company, reports today, that preliminary 2nd quarter 2012 revenue sustained a record breaking increase of 40% for its first two months, in comparison to the same two months of 2011. This most satisfying sales growth is largely the result of an aggressive Social Media Marketing Strategy introduced by the Company in the fall of 2011. The same marketing efforts brought on 87% increase in the traffic on www.acnease.com, a designated website for Herborium's unique, all botanical ingredients based acne product targeting over 135 million acne sufferers in US and Europe. Herborium's Investor Awareness Program has also contributed to this growth.
Dr. Agnes Olszewski, Herborium's Chairmen and CEO stated: "I am extremely pleased with these preliminary results that indicate that our 2012 sales revenues should achieve significant all year increase as we enter into several exciting new markets for our current and new products. Social Media Marketing initiatives along with our February 2012 announced Investor Awareness programs will continue to have a significant upward impact on our revenues and share price."
"Increase in revenue is an important factor that should allow the Company to move forward with number of initiatives including the repurchasing of shares announced in our April 23rd, 2012 Press Release. Shareholder value is very important to us as we make strides into new revenue streams and we will continue to update our shareholders of our progress moving forward," concluded Dr. Olszewski.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company uses clinical validation to establish and maintain a differential advantage. The company markets its products in the US and Europe. For more information, please visit www.herborium.com and www.acnease.com.
One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.
For more information please inquire: Investorsrelations@herborium.com
SOURCE Herborium Group, Inc.
Everything is IMO, "In My Opinion." Trade your own risk.
MrK
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM
Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • INTV • May 15, 2024 10:30 AM